{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T21:12:52Z","timestamp":1754601172973,"version":"3.41.2"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Aseptic abscesses syndrome is a rare but increasingly recognized disease that falls within the spectrum of autoinflammatory disorders. Here, we describe the case of a patient who presented with abdominal pain and fever, along with multiple abdominal and extra-abdominal abscesses, in the absence of underlying hematologic, autoimmune, infectious, or neoplastic conditions. Initially, the patient responded to glucocorticoids, but experienced several flares upon discontinuation, leading to the initiation of treatment with a TNF\u03b1 inhibitor. After 5 years, an attempt to discontinue treatment resulted in a new flare of the disease. Remission was eventually achieved with a biosimilar TNF\u03b1 inhibitor, albeit requiring shortened infusion intervals.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1454813","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T05:10:09Z","timestamp":1733202609000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Aseptic abscess syndrome: a case report of a patient achieving remission with both infliximab originator and biosimilar administered at varied intervals"],"prefix":"10.3389","volume":"15","author":[{"given":"Federica Maria","family":"Ucci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossana","family":"Scrivo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiano","family":"Alessandri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Conti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Priori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02064360","article-title":"Aseptic systemic abscesses preceding diagnosis of Crohn\u2019s disease by three years","volume":"40","author":"Andre","year":"1995","journal-title":"Dig Dis Sci"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/md.0b013e18064f9f3","article-title":"Aseptic abscesses: a study of 30 patients with or without inflammatory bowel disease and review of the literature","volume":"86","author":"Andr\u00e9","year":"2007","journal-title":"Med (Baltimore)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.3390\/jcm11133669","article-title":"Aseptic abscess syndrome: clinical characteristics, associated diseases, and up to 30 years\u2019 evolution data on a 71-patient series","volume":"11","author":"Trefond","year":"2022","journal-title":"J Clin Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1998.00311.x","article-title":"Aberrant neutrophil trafficking and metabolic oscillations in severe pyoderma gangrenosum","volume":"111","author":"Adachi","year":"1998","journal-title":"J Invest Dermatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1998.00255.x","article-title":"Aberrant integrin (CR4; alpha[x]beta2; CD11c\/CD18) oscillations on neutrophils in a mild form of pyoderma gangrenosum","volume":"111","author":"Shaya","year":"1998","journal-title":"J Invest Dermatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-007-9871-8","article-title":"Analysis of the NOD2\/CARD15 gene in patients affected with the aseptic abscesses syndrome with or without inflammatory bowel disease","volume":"53","author":"Andr\u00e9","year":"2008","journal-title":"Dig Dis Sci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.revmed.2011.02.001","article-title":"Le syndrome des abc\u00e8s aseptiques","volume":"32","author":"Andr\u00e9","year":"2011","journal-title":"Rev Med Interne"},{"key":"B8","doi-asserted-by":"publisher","first-page":"5124354","DOI":"10.1155\/2017\/5124354","article-title":"Aseptic abscesses and inflammatory bowel disease: two cases and review of literature","volume":"2017","author":"Bollegala","year":"2017","journal-title":"Can J Gastroenterol Hepatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3109\/s10165-012-0640-y","article-title":"A case of aseptic abscesses syndrome treated with corticosteroids and TNF-alpha blockade","volume":"23","author":"Ito","year":"2013","journal-title":"Mod Rheumatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3109\/14397595.2013.852835","article-title":"Efficacy of Il-1\u03b2 blockade in refractory aseptic abscesses syndrome","volume":"24","author":"Bardy","year":"2014","journal-title":"Mod Rheumatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.3748\/wjg.v19.i20.3165","article-title":"Beh\u00e7et\u2019s disease complicated by multiple aseptic abscesses of the liver and spleen","volume":"19","author":"Maeshima","year":"2013","journal-title":"World J Gastroenterol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1177\/1721727X1201000119","article-title":"Aseptic abscess: a report of two cases","volume":"10","author":"Isik","year":"2012","journal-title":"Eur J Inflamm"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00256-023-04493-3","article-title":"Aseptic abscess associated with SAPHO syndrome: a case report","volume":"53","author":"Kim","year":"2024","journal-title":"Skeletal Radiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.3390\/medicina58101354","article-title":"Aseptic abscess syndrome in rheumatoid arthritis patient","volume":"58","author":"Owczarczyk-Saczonek","year":"2022","journal-title":"Medicina (Mex.)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31547","article-title":"Aseptic liver abscesses as an exceptional finding in Cogan\u2019s syndrome","volume":"73","author":"Hafner","year":"2021","journal-title":"Hepatology"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2014.2435","article-title":"Aseptic muscular abscesses associated with myelodysplastic syndrome","volume":"24","author":"Mirouse","year":"2014","journal-title":"Eur J Dermatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41395-018-0163-z","article-title":"Aseptic abscess syndrome, a case of prolonged remission following splenectomy","volume":"113","author":"Doll","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4103\/ijd.IJD_259_18","article-title":"Aseptic abscess syndrome with severe skin involvement: case report","volume":"65","author":"Agirgol","year":"2020","journal-title":"Indian J Dermatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e236437","DOI":"10.1136\/bcr-2020-236437","article-title":"Aseptic abscess syndrome","volume":"13","author":"Fillman","year":"2020","journal-title":"BMJ Case Rep"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.14147","article-title":"Successful targeted cytokine blockade in a case of aseptic abscess syndrome","volume":"18","author":"Weins","year":"2020","journal-title":"J Dtsch Dermatol Ges"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2019.09.056","article-title":"TNF-\u03b1 antagonist infliximab for aseptic abscess syndrome","volume":"48","author":"Elessa","year":"2019","journal-title":"Presse Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1454813\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T05:10:12Z","timestamp":1733202612000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1454813\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,3]]},"references-count":21,"alternative-id":["10.3389\/fimmu.2024.1454813"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1454813","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2024,12,3]]},"article-number":"1454813"}}